Confronto
Exenatide vs. Semaglutid
Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.
Identità
Categoria
Metabolico
Metabolico
N. CAS
141758-74-9
910463-68-2
Peso molecolare
4186.6 g/mol
4113.6 g/mol
Emivita
2.4 h
165 h
Sequenza
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPSmodifiziertes GLP-1-Analogon (31 AS) mit C18-Fettsäure-LinkerMeccanismo d'azione
Exenatide
Exenatide is a 39-amino-acid peptide with about 53% sequence homology to human GLP-1. A glycine substitution at position 2 prevents dipeptidyl-peptidase-IV cleavage and extends the half-life from native GLP-1 (minutes) to about 2.4 hours. GLP-1 receptor activation glucose-dependently stimulates insulin secretion, inhibits glucagon and delays gastric emptying.
Semaglutid
Long-acting agonist at the GLP-1 receptor. Structurally a modified glucagon-like peptide 1 whose long half-life is achieved via a fatty-acid side chain and reversible albumin binding. Acts centrally on satiety and peripherally on glucose-dependent insulin secretion and delayed gastric emptying.
Base di evidenze
Evidenza più alta
RCT sull'uomo
RCT sull'uomo
Studi
5
4
di cui sull'uomo
4
3
Effetti registrati
3
3
Contraddizioni aperte
1
1
Eventi avversi documentati
2
5
Stato legale
Voci complete
Frequently asked questions
- What is the difference between Exenatide and Semaglutid?
- Exenatide is classified as "Metabolico", while Semaglutid is classified as "Metabolico". Exenatide: Synthetic version of exendin-4, originally isolated from the saliva of the Gila monster (Heloderma suspectum). First GLP-1 receptor agonist, FDA-approved 2005 as Byetta. Weekly depot form Bydureon approved 2012. Semaglutid: Long-acting GLP-1 receptor agonist. Approved as a medicinal product for type-2 diabetes (Ozempic, Rybelsus), chronic weight management (Wegovy) and cardiovascular risk in obesity. One of the best-studied substances on this platform — many large human RCTs. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Exenatide or Semaglutid?
- The highest available evidence level is "RCT sull'uomo" for Exenatide and "RCT sull'uomo" for Semaglutid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Exenatide and Semaglutid in Germany and the United States?
- Germania: Exenatide — Su prescrizione, Semaglutid — Su prescrizione. Stati Uniti: Exenatide — Su prescrizione, Semaglutid — Su prescrizione. These are factual summaries with source and review date on the individual pages.